Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    • News

  • March 2025 quarter CPI above expectations – but RBA cut still likely
    March 2025 quarter CPI above expectations – but RBA cut still likely
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

  • Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    • News

  • Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    • News

  • Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    • News

  • Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    • News

  • Spenda Secures $3M Term Loan to Accelerate Growth
    Spenda Secures $3M Term Loan to Accelerate Growth
    • News

Findi deploys 1,000th ATM ahead of schedule to support India’s cash economy

  • In News
  • December 19, 2022
  • Alinda Gupta
Findi deploys 1,000th ATM ahead of schedule to support India’s cash economy

In less than a month after deploying its 500th ATM, FinTech company Findi (ASX: FND) has unlocked a new milestone on its India journey. The Company has surpassed the deployment of 1,000 ATMs for the Central Bank of India (CBI) ahead of schedule. 

While much of the country has transitioned to digital payments (with over 72 billion virtual transactions recorded in FY22), India’s rural segments continue to be cash-starved and -reliant. Rural India’s dependence on ATMs and the need for greater ATM penetration is proving successful for Findi, which has been brought on by the CBI and the State Bank of India to set up the machines across the country.

In the Indian market, cash in circulation has increased by 16% CAGR over the last five years while 80% of eCommerce is now conducted via cash in non-metropolitan areas. Findi’s strategy is backed by these market dynamics as it seeks to have a customer ecosystem of cash, payments and digital transactions.

The majority of the latest 500 ATMs deployed are located in rural and semi-rural areas of India, where cash transactions are far more prevalent than the metro areas. The availability of Findi’s ATMs in these regions supports financial inclusion and enables transactions for the unbanked population.

In March of this year, the Company signed a five-year contract with the Central Bank of India to deploy 2,550 ATMs across the country. Ten months in, it is about halfway through this goal. 

Findi is all set to deploy ATMs faster as CBI tries to approve as many sites as possible for operation. Thanks to that, the deployment of the remaining 1,550 ATMs is on track to be completed by the end of FY23.

The new 1,000 ATMs under the CBI contract utilise Findi’s new Ticket Management Platform (TMP). It has lowered monthly recurring costs and enabled additional features like seamlessly integrating multiple customers, vendors and in-house applications. Plus, it allows for integration with multiple switches, thus delivering a scalable platform. The TMP makes Findi white-label ATM ready while eliminating third-party vendor dependencies.

Findi Limited Chairman, Nicholas Smedley, commented, “The implementation of our proprietary new Ticket Management Platform is industry leading and, pleasingly, our speed of deployment for CBI has accelerated, despite additional holidays in India through the second half of the year”

Owning and managing ATMs in India—as Findi does—is no cakewalk. In October last year, India’s central bank, the Reserve Bank of India, stated that in case an ATM runs out of cash for more than 10 hours, the bank has to pay over $180 as a fine, which could eventually lead to the ATMs shutting shop. 

Thankfully for Findi, the ATMs deployed seem to be at a safe distance from such problems. The installed ATMs continue to show strong transaction trends, with ATMs in place longer than 90 days averaging over 100 transactions per day per ATM. 

Poring over the progress of the CBI contract, now, there are over 1,000 sites live and transacting, 1,000 sites approved by the CBI, and 550 sites awaiting approval by the CBI. Overall, this contract remains on track to usher in revenue of $25 to 30 million per year, and an annual EBITDA of $11-$13 million. 

The CBI contract along with the State Bank of India contract extension have positioned the Company for success. Sharing updated profit guidance with shareholders, Findi noted its new revenue guidance of $51-53 million (an increase of up to 13% on the original guidance), and EBITDA of $14.5-15.5 million (an increase of up to 19%) for this financial year. 

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx fnd
  • atm
  • Fintech
  • fnd
  • ticket management
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.